Drug intelligence / Profile preview

GiGA1

Development stage
Preclinical
Lead developer
National Center for Advancing Translational Sciences
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

GiGA1 (G protein-independent GIRK Activator 1) is a selective, small-molecule agonist of G protein-gated inwardly rectifying potassium (GIRK) channels, specifically targeting GIRK1/GIRK2 heterotetramers. Discovered through a structure-based virtual screening of the alcohol-binding pocket in GIRK channels, GiGA1 acts in a G-protein-independent manner to activate GIRK1-containing channels with rapid activation and deactivation kinetics. By enhancing potassium conductance, GiGA1 hyperpolarizes neurons and reduces excitability in the brain. It has demonstrated preclinical efficacy as an anticonvulsant in animal models of acute chemoconvulsant-induced seizures and tumor-associated epilepsy (TAE), and is also being investigated for its potential to reduce alcohol-mediated behaviors in models of alcohol use disorder (AUD).

Other names
1-(thiophen-2-yl)-3-(o-tolyl)ureaG protein-independent GIRK activator 1G-protein-independent GIRK activator 1
02

Targets

KCNJ3 (GIRK1)KCNJ6 (G protein-activated inward rectifier potassium channel 2)

Beyond the preview

Go deeper on GiGA1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GiGA1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call